Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-23-000007

Chief Executive Officer gave up 42,273 shares (to pay taxes)

  • Chief Executive Officer acquired 92,778 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-26 Exercise or conversion : show line 1 in the form +22,544 99,099 D
2023-02-26 Shares withheld for taxes : show line 2 in the form −9,788 $1.28 $12,529 89,311 D
2023-02-26 Exercise or conversion : show line 3 in the form +70,234 159,545 D
2023-02-26 Shares withheld for taxes : show line 4 in the form −32,485 $1.28 $41,581 127,060 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −22,544 22,544 D
2023-02-26 Exercise or conversion : show line 6 in the form Restricted Stock Unit −70,234 140,466 D
2023-02-27 Grant or award : show line 7 in the form Common Stock Option +836,800 836,800 D
Loading xslF345X03/wf-form4_167762425136925.xml…